Patent Assignment
Reel/Frame 055982/0903
Assignment of Assignor's Interest
Recorded: 2021-04-21
Pages: 9
Assignors
BLATTER, FRITZ
Executed: 2015-11-18
INGALLINERA, TIM
Executed: 2015-11-17
BARF, TJEERD
Executed: 2015-11-17
ARET, EDWIN
Executed: 2015-11-18
KREJSA, CECILE
Executed: 2015-11-18
EVARTS, JERRY
Executed: 2015-11-18
Assignee
ACERTA PHARMA B.V.
PIVOT PARK ROOM RK 2111, MOLENWEG 79, OSS, 5349 AC, NETHERLANDS
Covered Properties
(3)
Crystal Forms of (S)-4-(8-Amino-3-(1-(But-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-A]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)Benzamide
PHARMACEUTICAL COMPOSITION COMPRISING A CRYSTAL FORM OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-a]PYRAZIN-1-YL)-N-(PYRIDIN-2-YL)BENZAMIDE
Pharmaceutical Composition Comprising a Crystal Form of (S)-4-(8-Amino-3-(1-(but-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-a]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)Benzamide for Treating Diffuse Large B-Cell Lymphoma